guiding clinicians to recognize toxicity levels of newer immunotherapy agents
Published 6 years ago • 30 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
0:43
the rarer toxicities of immunotherapy
-
5:49
immunotherapy toxicity and duration of therapy
-
21:39
developing effective immune therapies to treat cancer
-
8:42
immunotherapy: the path to a cancer cure (for clinicians)
-
1:05:22
2012 cic roundtable: benefit/risk of immunotherapy
-
1:05:53
cancer immunotherapy beyond 2020
-
30:34
melanoma and immunotherapy with dr. margaret callahan and sharon belvin
-
7:53
duration of immunotherapy in melanoma
-
47:06
management of toxicities in an outpatient setting with krista rubin, ms, fnp-bc
-
0:16
cancer immunotherapy: what you need to know i mrmed
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
2:22
immunotherapy toxicities and checkpoint inhibitor therapy
-
4:27
new immunotherapies in trial
-
52:47
complications of immunotherapy in oncology, 12/2/20
-
5:01
immunotherapy toxicity: how much do physicians know
-
20:33
approach to immunotherapy related toxicity
-
47:48
“neurologic toxicities of immunotherapy” by dr. gopika govindan kutty
-
8:56
managing toxicity of immunotherapy in melanoma
-
1:57:09
new concepts in immunotherapy for solid tumors